115
Participants
Start Date
March 19, 2019
Primary Completion Date
November 30, 2024
Study Completion Date
August 31, 2025
KRT-232
KRT-232 is an experimental MDM2 anticancer drug taken by mouth.
Avelumab
Avelumab is a PD-L1 blocking antibody anticancer drug administered by intravenous infusion.
RECRUITING
Memorial Sloan-Kettering Cancer Center, New York
RECRUITING
Mount Sinai Hospital, New York
RECRUITING
UPMC Hillman Cancer Center, Pittsburgh
RECRUITING
Inova Health Care Services, Fairfax
RECRUITING
Miami Cancer Institute, Miami
RECRUITING
Moffitt, Tampa
RECRUITING
Norton Healthcare, Louisville
RECRUITING
University of Michigan, Ann Arbor
RECRUITING
Northwestern Memorial Hospital, Chicago
RECRUITING
University of Texas MD Anderson, Houston
RECRUITING
University of Colorado Anschutz Medical Campus, Aurora
RECRUITING
Massachusetts General Hospital, Boston
RECRUITING
Dana-Farber Cancer Institute, Boston
ACTIVE_NOT_RECRUITING
Fox Chase Cancer Center, Philadelphia
RECRUITING
Princess Alexandra Hospital Oncology, Woolloongabba
RECRUITING
Centro Catarinense de Pesquisa (CECAP) - Hospital Santa Catarina de Blumenau, Blumenau
RECRUITING
Instituto Nacional do Cancer, Brasília
RECRUITING
Centro Intergado de Oncologia, Curitiba
RECRUITING
Centro de Pesquisa Clinica em Oncologia, Ijuí
RECRUITING
Clinica De Neoplasias Litoral, Itajaí
RECRUITING
Hospital Paulistano, São Paulo
RECRUITING
Princess Margaret Cancer Centre, Toronto
RECRUITING
CHU de Bordeaux- Hopital Saint-Andre, Bordeaux
RECRUITING
AP-HP Universite Paris Saclay, Gif-sur-Yvette
RECRUITING
CHU de Lille, Lille
RECRUITING
CHU Lyon-Sud, Lyon
RECRUITING
CHU Montpellier, Montpellier
RECRUITING
CHU de Nantes, Nantes
RECRUITING
Hôpital Saint Louis - APHP, Paris
RECRUITING
CHU de Tours, Tours
RECRUITING
Vivantes Network for Health Gmb, Neukölln Clinic, Berlin
RECRUITING
Uniklinik Koln, Cologne
RECRUITING
Universitätsklinikum Erlangen, Erlangen
RECRUITING
Universitätsklinikum Essen (AöR), Essen
RECRUITING
Nationales Centrum für Tumorerkrankungen NCT, Heidelberg
RECRUITING
Universitätsklinik Rostock, Rostock
RECRUITING
Universitats-Hautklinik Tubingen, Tübingen
RECRUITING
Institute for Cancer Research and Treatment, Candiolo
RECRUITING
Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli
RECRUITING
AUSL della Romagna, Ravenna
RECRUITING
AOUS Le Scotte, Siena
RECRUITING
OSP Civile Maggiore Borgo Trento, Verona
RECRUITING
University Medical Center Groningen, Groningen
RECRUITING
National Cancer Center, Goyang-si
RECRUITING
Seoul National University Hospital, Seoul
RECRUITING
Severance Hospital Yonsei University Health System, Seoul
RECRUITING
Hospital Duran i Reynals, Barcelona
RECRUITING
Hospital General Universitario Gregorio Marañn (Madrid), Madrid
RECRUITING
Complejo Hospitalario de Navarra, Pamplona
RECRUITING
Fundacio Investigao Hospital General Universitario de Valencia, Valencia
RECRUITING
Hôpital de la Timone. Aix-Marseille Université, Marseille
Lead Sponsor
Kartos Therapeutics, Inc.
INDUSTRY